MedTrace Logo

ICA-CHAMP: Indo-Central Asian Cardiovascular Health Assessment and Management Program

NCT00627159 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 375

Last updated 2008-02-29

No results posted yet for this study

Summary

Research has shown that the presence of heart disease and stroke is higher in the Indo-Asian population compared to other ethno-cultural groups. This may be due to multiple reasons such as a higher presence of diabetes, high blood pressure, high cholesterol, obesity, and lower levels of physical activity.

This program will bring together the Calgary Indo-Central-Asian communities and the Calgary Healthcare community to help reduce the rate of heart disease and stroke through a supportive, culturally-sensitive program that is community-based through the following steps:

1. Increase awareness of heart disease and stroke through education among the Calgary Indo-Central-Asian population.
2. Identify early, the risk factors related to heart disease and stroke through screening programs.
3. Provide appropriate follow-up care to the population at risk for heart disease and stroke.

Conditions

Interventions

OTHER

High risk assessment

For all participants screened in the program, a cardiovascular risk profile is determined using information from the cardiovascular health history, blood pressure and cholesterol measurements, and The British Joint Societies Risk Prediction chart. All participants predicted to be at high risk are referred for assessment to a High Risk clinic in the community via the family doctor.

OTHER

Low to moderate risk

For all participants screened in the program, a cardiovascular risk profile is determined using information from the cardiovascular health history, blood pressure and cholesterol measurements, and The British Joint Societies Risk Prediction chart. All low to -moderate risk participants are directed to self-refer to the Calgary Health Region Multicultural education classes.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Calgary

    lead OTHER

Principal Investigators

  • Charlotte - Jones, PhD, MD · University of Calgary

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-04-30
Completion
2008-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00627159 on ClinicalTrials.gov